Helsinn Investment Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Investments
  • 12
  • Portfolio
  • 9
  • Exits
  • 2
Exits

Helsinn Investment Fund General Information

Description

Founded in 2016, Helsinn Investment Fund is the corporate venture arm of Helsinn Group based in Luxembourg, Luxembourg. The firm focuses on privately-owned companies with early-stage technologies in oncology, biotechnology, pharmaceutical, medical devices, and food supplements.

Contact Information

Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 412F, route d'Esch
  • Luxembourg, 2086
  • Luxembourg

Helsinn Investment Fund Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
iOnctura 14-Jul-2020 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 00000000 0000000
0000 000000000000 19-Feb-2019 00000 00000 0000 Drug Discovery Generating Revenue 00000000 0000000
0000 000000000000 12-Nov-2018 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 00000000 0000000
000000000000 11-Sep-2018 00000 00000 0000 Biotechnology Pre-Clinical Trials
0000000000 30-Apr-2018 00000 00000 000 Drug Discovery Clinical Trials - Phase 1 0000000 00 00000
00 000000 00000000 14-Mar-2018 00000 00000 0000 Surgical Devices Clinical Trials - Phase 2
00000000 000000 00 04-Jan-2018 00000 00000 0000 Biotechnology Generating Revenue
000000000 16-Jun-2017 00000 00000 00.00 Surgical Devices Generating Revenue
Aadi Bioscience 08-May-2017 Early Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
OncoResponse 23-Mar-2017 Early Stage VC 000.00 Biotechnology Pre-Clinical Trials
You’re viewing 10 of 12 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Helsinn Investment Fund Exits (2)

Company Name Exit Date Exit Type Exit Size
Amal Therapeutics 15-Jul-2019 Merger/Acquisition 00000
000 000000 000000000 00000000
To view Helsinn Investment Fund’s complete exits history, request access »

Helsinn Investment Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Helsinn Investment Fund Team (4)

Name Title Deals Funds Boards Office
Roberto De Ponti Advisor 0 0 Luxembourg, Luxembourg
Sandra van Essche JD Advisor and Consultant Luxembourg, Luxembourg
Hanna Kleczkowska Ph.D Principal Investment Advisor Luxembourg, Luxembourg
Karin Hehenberger Ph.D Advisor and Consultant 0 Luxembourg, Luxembourg
To view Helsinn Investment Fund’s complete team members history, request access »

Helsinn Investment Fund Co-Investors (50)

Name With Exits Lead Partner Series Industry
Helsinn Healthcare 4 0 Series chart Industry bar
Schroder Adveq Management 0 0 0 Series chart Industry bar
VI Partners 0 0 0 Series chart Industry bar
Windham Venture Partners 0 0 Series chart Industry bar
H.I.G. Capital 0 Series chart Industry bar
You’re viewing 5 of 50 co-investors. Get the full list »